全文获取类型
收费全文 | 4922篇 |
免费 | 349篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 126篇 |
妇产科学 | 65篇 |
基础医学 | 482篇 |
口腔科学 | 155篇 |
临床医学 | 401篇 |
内科学 | 1249篇 |
皮肤病学 | 63篇 |
神经病学 | 275篇 |
特种医学 | 90篇 |
外国民族医学 | 1篇 |
外科学 | 773篇 |
综合类 | 128篇 |
一般理论 | 2篇 |
预防医学 | 322篇 |
眼科学 | 177篇 |
药学 | 542篇 |
中国医学 | 78篇 |
肿瘤学 | 333篇 |
出版年
2024年 | 8篇 |
2023年 | 67篇 |
2022年 | 179篇 |
2021年 | 234篇 |
2020年 | 144篇 |
2019年 | 175篇 |
2018年 | 201篇 |
2017年 | 102篇 |
2016年 | 174篇 |
2015年 | 178篇 |
2014年 | 225篇 |
2013年 | 274篇 |
2012年 | 413篇 |
2011年 | 410篇 |
2010年 | 195篇 |
2009年 | 159篇 |
2008年 | 281篇 |
2007年 | 265篇 |
2006年 | 244篇 |
2005年 | 233篇 |
2004年 | 209篇 |
2003年 | 181篇 |
2002年 | 155篇 |
2001年 | 73篇 |
2000年 | 73篇 |
1999年 | 59篇 |
1998年 | 43篇 |
1997年 | 23篇 |
1996年 | 24篇 |
1995年 | 20篇 |
1994年 | 24篇 |
1993年 | 14篇 |
1992年 | 25篇 |
1991年 | 26篇 |
1990年 | 15篇 |
1989年 | 23篇 |
1988年 | 18篇 |
1987年 | 13篇 |
1986年 | 19篇 |
1985年 | 15篇 |
1984年 | 11篇 |
1983年 | 10篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1974年 | 6篇 |
1973年 | 6篇 |
1966年 | 6篇 |
排序方式: 共有5306条查询结果,搜索用时 15 毫秒
81.
Embolic protection device use and its association with procedural safety and long‐term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry 下载免费PDF全文
M. Bilal Iqbal MD PhD Imad J. Nadra MD Lillian Ding MSC Anthony Fung MD Eve Aymong MD Albert W. Chan MD Steven Hodge MD Anthony Della Siega MD Simon D. Robinson MD 《Catheterization and cardiovascular interventions》2016,88(1):73-83
- Coronary stents are commonly deployed using high pressure. However, the duration time of balloon inflation during deployment is still to be determined.
- Vallurupalli and coworkers, in this issue of CCI, show that the stent system takes an average of 33 sec to “accommodate” its pressure during in vitro deployment. In patients, the mean stent inflation time to achieve pressure stability was 104 seconds, ranging from 30 to 380 sec.
- These results challenge a rapid inflation/deflation approach for stent deployment. It is suggested that the duration of the inflation might be individualized, in a case‐by‐case approach.
- However, the findings must be interpreted with caution, as they cannot be directly extrapolated to more diverse clinical, angiographic, and interventional scenarios.
82.
Ahmad Alghadir Hamayun Zafar Zaheen A. Iqbal 《Journal of Physical Therapy Science》2015,27(4):1107-1112
[Purpose] Musculoskeletal disorders are common causes of work-related disability in
different professions involving the frequent practice of lifting, stooping, twisting,
prolonged sitting, or standing. The dental profession is one such profession. Our aim was
to determine the prevalence of work-related musculoskeletal disorders among dental
professionals in Saudi Arabia, the factors associated with them, and their consequences
and to propose preventive measures for them. [Subjects and Methods] A self-administered
online questionnaire was sent to 225 members of the Saudi Dental Association. It included
questions on demographic and professional characteristics, general medical history, and
history of work-related musculoskeletal disorders before and after joining the dental
profession. [Results] The questionnaire was completed by 65% of the respondents. Among
them 85% reported that they had developed some pain due to work after joining the dental
profession, and 42% reported that they were suffering pain at the time of the survey.
Besides lower back, shoulder, and neck regions, the hands, upper back, and other regions
like the elbows, buttocks, thighs, leg, and feet were areas in which they pain.
[Conclusion] The prevalence of work-related musculoskeletal disorders among dental
professionals in Saudi Arabia is high, affecting their daily activities, sometimes even
forcing them to change their work setting. Age, gender, specialty of work, work setting,
number of contact hours with patients, etc., were all found to be related to their
work-related pain. We need to emphasize the role of ergonomics, counseling, proper
techniques of patient handling, etc., during the training of dental professionals so that
they can work efficiently.Key words: Work-related musculoskeletal disorders, Dentists, Saudi Arabia 相似文献
83.
Yakoob J Rasool S Abbas Z Jafri W Abid S Islam M Ahmad Z 《World journal of gastroenterology : WJG》2008,14(10):1539-1543
AIM: To determine the efficacy of gastric juice polymerase chain reaction (PCR) for the detection of H pylori infection in comparison with histology and gastric antral biopsy PCR in patients on a proton pump inhibitor (PPI). METHODS: Eighty-five consecutive patients with dyspeptic symptoms were enrolled. Gastric biopsies for histology, PCR and gastric juice were collected at endoscopy for PCR of the H pylori urease C gene (ure C). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, positive and negative likelihood ratio for PCR of gastric juice for the H pylori ure C gene was compared to histology and gastric antral biopsy H pylori ure C PCR in patients with and without PPI. RESULTS: Gastric juice PCR was positive in 66 (78%) patients. Histology showed H pylori associated gastritis in 57 (67%). Gastric biopsy PCR was positive in 72 (85%). In patients not taking PPI, the sensitivity, specificity, PPV, NPV, accuracy and positive and negative likelihood ratio for gastric juice PCR were 89%, 72%, 91%, 67%, 90%, 85%, 3.1 and 0.1 respectively. In patients on PPI these values were 86%, 100%%, 100%, 29%, 86%, 9.5 and 1.4, respectively. CONCLUSION: Gastric juice PCR for the diagnosis of H pylori infection has increased sensitivity compared to histology with PPI. The use of gastric juice PCR is recommended to confirm H pylori status in patients taking PPIs. 相似文献
84.
Prabhjot Singh Shilpa Vijayakumar Andreas Kalogeroupoulos Javed Butler 《Current heart failure reports》2018,15(2):44-52
Purpose of review
This review discusses the integral role of the nitric oxide (NO) pathway in the pathophysiology of heart failure (HF). We emphasize potential therapeutic targets in the NO pathway and review contemporary clinical trials evaluating these novel therapeutic options.Recent findings
Nitrates, neprilysin inhibitors, and phosphodiesterase (PDE) inhibitors have all proven to be efficacious in HF patients with systolic dysfunction, with the former two classes of medications producing a net mortality benefit. However, neither PDE inhibitors nor nitrates have demonstrated significant clinical benefit in patients with HF with preserved ejection fraction (HFpEF), and neprilysin inhibitors have yet to be evaluated in this population. Soluble guanylate cyclase (sGC) stimulators have shown significant promise in all HF patients, leading to improvements in both quality of life scores and exercise capacity. Conversely, sGC activators have limited clinical utility in HF, owing largely to safety concerns of hypotension. Inorganic nitrates and nitrites, meanwhile, may be emerging as potential therapies for the HFpEF population.Summary
The advent of novel therapies targeting the NO pathway is beginning to create a paradigm shift in the treatment of the HF patient. These therapies offer a promising outlook for the future, with hopes of reducing HF-associated morbidity and mortality.85.
Purpose of review
Several novel therapeutics being tested in patients with heart failure are based on myocardial energetics. This review will provide a summary of the recent trials in this area, including therapeutic options targeting various aspects of cellular and mitochondrial metabolism.Recent findings
Agents that improve the energetic balance in myocardial cells have the potential to improve clinical heart failure status. The most promising therapies currently under investigation in this arena include (1) elamipretide, a cardiolipin stabilizer; (2) repletion of iron deficiency with intravenous ferrous carboxymaltose; (3) coenzyme Q10; and (4) the partial adenosine receptor antagonists capadenoson and neladenosone.Summary
Myocardial energetics-based therapeutics are groundbreaking in that they utilize novel mechanisms of action to improve heart failure symptoms, without causing the adverse neurohormonal side effects associated with current guideline-based therapies. The drugs appear likely to be added to the heart failure therapy armamentarium as adjuncts to current regimens in the near future.86.
87.
88.
89.
Mahim Khan Waqar Rauf Fazal-e- Habib Moazur Rahman Mazhar Iqbal 《World journal of hepatology》2020,12(11):976-992
BACKGROUNDHepatitis C virus genotype 3a (HCV G3a) is highly prevalent in Pakistan. Due to the elevated cost of available Food and Drug Administration-approved drugs against HCV, medicinal natural products of potent antiviral activity should be screened for the cost-effective treatment of the disease. Furthermore, from natural products, active compounds against vital HCV proteins like non-structural protein 3 (NS3) protease could be identified to prevent viral proliferation in the host.AIMTo develop cost-effective HCV genotype 3a NS3 protease inhibitors from citrus fruit extracts.METHODSFull-length NS3 without co-factor non-structural protein 4A (NS4A) and codon optimized NS3 protease in fusion with NS4A were expressed in Escherichia coli. The expressed protein was purified by metal ion affinity chromatography and gel filtration. Citrus fruit extracts were screened using fluorescence resonance energy transfer (FRET) assay against the protease and polyphenols were identified as potential inhibitors using electrospray ionization-mass spectrometry (MS)/MS technique. Among different polyphenols, highly potent compounds were screened using molecular modeling approaches and consequently the most active compound was further evaluated against HCV NS4A-NS3 protease domain using FRET assay.RESULTSNS4A fused with NS3 protease domain gene was overexpressed and the purified protein yield was high in comparison to the lower yield of the full-length NS3 protein. Furthermore, in enzyme kinetic studies, NS4A fused with NS3 protease proved to be functionally active compared to full-length NS3. So it was concluded that co-factor NS4A fusion is essential for the purification of functionally active protease. FRET assay was developed and validated by the half maximal inhibitory concentration (IC50) values of commercially available inhibitors. Screening of citrus fruit extracts against the native purified fused NS4A-NS3 protease domain showed that the grapefruit mesocarp extract exhibits the highest percentage inhibition 91% of protease activity. Among the compounds identified by LCMS analysis, hesperidin showed strong binding affinity with the protease catalytic triad having S-score value of -10.98.CONCLUSIONFused NS4A-NS3 protease is functionally more active, which is effectively inhibited by hesperidin from the grapefruit mesocarp extract with an IC50 value of 23.32 µmol/L. 相似文献
90.
The use of fibers in cementitious composites yields numerous benefits due to their fiber-bridging capabilities in resisting cracks. Therefore, this study aimed to improve the shear-resisting capabilities of conventional concrete through the hybridization of multiple synthetic fibers, specifically on reinforced concrete structures in seismic-prone regions. For this study, 16 hybrid fiber-reinforced concretes (HyFRC) were developed from the different combinations of Ferro macro-synthetic fibers with the Ultra-Net, Super-Net, Econo-Net, and Nylo-Mono microfibers. These hybrids were tested under direct shear, resulting in improved shear strength of controlled specimens by Ferro-Ultra (32%), Ferro-Super (24%), Ferro-Econo (44%), and Ferro-Nylo (24%). Shear energy was further assessed to comprehend the effectiveness of the fiber interactions according to the mechanical properties, dosage, bonding power, manufactured material, and form of fibers. Conclusively, all fiber combinations used in this study produced positive synergistic effects under direct shear at large crack deformations. 相似文献